Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Revenue Recognition (Details)

v3.22.2.2
Significant Accounting Policies - Revenue Recognition (Details) - USD ($)
3 Months Ended
Dec. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Disaggregation of Revenue [Line Items]      
Financial Designation, Predecessor and Successor [Fixed List] Successor Successor Predecessor
Total Revenue by Year   $ 273,544,334 $ 151,297,940
Revenue | Customer Concentration      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 273,544,334 $ 151,297,940
Percentage of total revenue   100.00% 100.00%
Capitated Revenue      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 269,684,815 $ 148,964,190
Capitated Revenue | Revenue | Customer Concentration      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 269,684,815 $ 148,964,190
Percentage of total revenue   98.60% 98.50%
Clinical Fees & Insurance Revenue | Revenue | Customer Concentration      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 1,882,254 $ 821,762
Percentage of total revenue   0.70% 0.50%
Care Coordination / Management Fees | Revenue | Customer Concentration      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 1,921,105 $ 1,503,353
Percentage of total revenue   0.70% 1.00%
Incentive Fees | Revenue | Customer Concentration      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 56,160 $ 8,635
Percentage of total revenue   0.00% 0.00%
Other Patient Service Revenue      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 3,859,519 $ 2,333,750
Other Patient Service Revenue | Revenue | Customer Concentration      
Disaggregation of Revenue [Line Items]      
Total Revenue by Year   $ 3,859,519 $ 2,333,750
Percentage of total revenue   1.40% 1.50%